A bottle of white prescription pills is spilled on a table. A collection of other prescription bottles are in the background. According to the filings, Master's conduct "greatly contributed to the vast increase in opioid overuse and addiction" and caused "a public-health and law-enforcement crisis." (Credit: Kimberly Boyles/Adobe Stock)

In a 5-2 decision, the Supreme Court of Ohio has ruled that lawsuits brought by governmental bodies against a prescription opioid distributor seeking damages merely related to opioid-related addiction and overdoses do not invoke an insurers' duty to defend. The case is Acuity v. Masters Pharm., 2022-Ohio-3092.

Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader

  • All PropertyCasualty360.com news coverage, best practices, and in-depth analysis.
  • Educational webcasts, resources from industry leaders, and informative newsletters.
  • Other award-winning websites including BenefitsPRO.com and ThinkAdvisor.com.
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Litigation